Medication info
SugarMet Extended-Release Tablet 2.5/500 mg

SugarMet Extended-Release Tablet 2.5/500 mg

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›500mg / 1 tabletEvogliptin Tartrate›3.4345mg / 1 tablet
Manufacturer / importer
Dong-A ST Co., Ltd.
Appearance
Soft pink oval film-coated tablet consisting of immediate-release and extended-release layers.
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201508555 · Approved 2015.12.31 · Insurance code 642507340

Summary

Main use
Improves glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: evogliptin 5 mg and metformin 2000 mg. This medicine is generally administered once daily with the evening meal, and the dose should be adjusted gradually to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this medicine 5/1000 mg extended-release tablet once daily. Patients taking this medicine 2.5/500 mg extended-release tablet or 2.5/850 mg extended-release tablet should take 2 tablets together once daily. For patients who cannot achieve adequate glycemic control with metformin monotherapy, the initial dose of this medicine should provide evogliptin 5 mg once daily and the patient's existing metformin dose. For patients switching to this medicine from combination therapy with evogliptin and metformin, treatment may be started at the existing doses of evogliptin and metformin. When switching from immediate-release metformin to an extended-release formulation, glycemic control should be closely monitored and the dose adjusted appropriately. No studies have been conducted to evaluate the safety and efficacy of switching to this medicine in patients previously treated with another oral antihyperglycemic agent. Any change in the treatment regimen for type 2 diabetes may alter glycemic control; therefore, caution should be exercised and appropriate monitoring should be performed. To maintain its extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.

Ingredients

Manufacturer
Dong-A ST Co., Ltd.

Efficacy & effects

Improves glycemic control in adults with type 2 diabetes mellitus

  • Type 2 diabetes
  • poor blood glucose control
View approved original text

This medicine is used for adult patients with type 2 diabetes who need blood glucose control in conjunction with dietary and exercise therapy. It is especially helpful when blood glucose control with metformin alone is difficult or as an alternative to combined therapy with evogliptin and metformin. This medicine is effective in improving blood glucose control and managing diabetes.

How to take

Adult dose

The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: evogliptin 5 mg and metformin 2000 mg. This medicine is generally administered once daily with the evening meal, and the dose should be adjusted gradually to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this medicine 5/1000 mg extended-release tablet once daily. Patients taking this medicine 2.5/500 mg extended-release tablet or 2.5/850 mg extended-release tablet should take 2 tablets together once daily. For patients who cannot achieve adequate glycemic control with metformin monotherapy, the initial dose of this medicine should provide evogliptin 5 mg once daily and the patient's existing metformin dose. For patients switching to this medicine from combination therapy with evogliptin and metformin, treatment may be started at the existing doses of evogliptin and metformin. When switching from immediate-release metformin to an extended-release formulation, glycemic control should be closely monitored and the dose adjusted appropriately. No studies have been conducted to evaluate the safety and efficacy of switching to this medicine in patients previously treated with another oral antihyperglycemic agent. Any change in the treatment regimen for type 2 diabetes may alter glycemic control; therefore, caution should be exercised and appropriate monitoring should be performed. To maintain its extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.

Precautions

This medicine helps with blood glucose control and there are several precautions to take when using it. Firstly, although rare, a serious condition called lactic acidosis may occur, which is a dangerous state caused by an excessive buildup of lactic acid in the body. This condition has a higher risk of occurrence in patients with impaired kidney function or heart problems; therefore, caution is advised. Additionally, hypoglycemia may occur when used with insulin or other diabetes medications, so blood glucose levels should be monitored closely. Patients with moderate to severe renal impairment, heart failure, acute heart issues or severe infections, liver dysfunction, and women who are pregnant or breastfeeding should not use this medicine. Patients scheduled for surgery should discontinue this medicine 48 hours prior to surgery and resume it only after confirming normal kidney function post-surgery. Caution should also be taken when this medicine is used by patients with irregular or insufficient food intake, those undergoing vigorous exercise, or those taking specific medications concurrently. If abdominal pain or sudden severe abdominal pain occurs during treatment, pancreatitis may be a possibility, so immediate consultation with a doctor is necessary. This medicine should be swallowed whole without breaking or chewing, and the shell may be expelled in the stool, which is normal. If health status changes due to renal impairment, liver dysfunction, excessive alcohol intake, dehydration, severe infections, etc., the use of this medicine should be stopped and medical consultation sought. Moreover, this medicine may lower vitamin B12 levels, so regular blood tests to monitor this are recommended. In case of overdose, immediate hospital treatment is required, and if necessary, blood dialysis can be used to remove the drug. Finally, children and the elderly should have their kidney function monitored regularly when using this medicine, and elderly patients should avoid maximum dosage for safety.

Side effects

Severe lactic acidosis, severe hypoglycemia, various gastrointestinal disorders, constipation, gastric disorders, nausea, abdominal pain, discomfort in the upper abdomen, gastroesophageal reflux disease, abnormal liver function tests, reduced renal creatinine clearance, weight loss, decreased blood urea, decreased appetite, hypouricemia, bronchitis, dizziness, gait disturbances, gastritis, periodontitis, rhinitis, erectile dysfunction, indigestion, arthralgia, diarrhea, pruritus, toothache, contact dermatitis, nausea, headache, abnormal olfaction, myalgia, urticaria, rash, drug hypersensitivity, hyperglycemic hyperosmolar non-ketotic syndrome, insomnia, palpitations, nasal bleeding, renal dysfunction, sexual dysfunction, diarrhea, nausea/vomiting, hypoglycemia, blistering pseudoporphyria, sciatica, palpitations, headache, abnormal olfaction, myalgia, urticaria, rash, drug hypersensitivity, insomnia, nasal bleeding, renal dysfunction, sexual dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine may be sensitive to air and moisture, so it should be stored in a tightly closed container. It is recommended to maintain storage temperatures between 1°C and 30°C to preserve the efficacy of the medicine for a longer period.

Appearance and packaging

Appearance

Soft pink oval film-coated tablet consisting of immediate-release and extended-release layers.

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.